A rare study on Chinese subjects yields interesting results.
Flax is known as a rich source of ALA omega-3, and limited research indicates that flax can even increase other omega-3s in the body.
Less is known of flax’s effect on people with metabolic syndrome, and even less is known of flax’s effect on people with metabolic syndrome who live in China, where flax is rarely consumed.
For 12 weeks, U.S. and Chinese researchers assigned 173 Chinese adults with risk factors of metabolic syndrome to life counseling and bread-bread containing 30 g of ground whole flaxseed (7 g of total ALA) or control bread. At baseline and the end of the study, blood samples were collected and analyzed for omega-3s and blood markers for common metabolic syndrome conditions: inflammation, oxidative stress, endothelial dysfunction, and thrombosis.
Those who consumed flax bread experienced significant increases in ALA, EPA, and DPA omega-3 and decreases in total omega-6 and ratio of omega-6 to omega-3.
But blood levels of DHA omega-3 did not increase-a finding that the researchers claim is consistent with many previous studies on Western populations. Why dietary ALA cannot individually convert to DHA in an efficient manner is still unclear. It could be related to conflicting human pathways for omega-3 conversion, it could even be that “our ancient diet, unlike modern ones, was rich in DHA; hence it is possible that the body has not developed additional means to convert sufficient DHA from ALA.”
Despite flax’s significant influence on certain omega-3s and ratio of omega-6 to omega-3, flax did not appear to benefit biomarkers of inflammation, oxidative stress, endothelial dysfunction, and thrombosis.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.